Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases

Fig. 1

Therapeutic potential of genetically modified stem cells in liver injuries. MSCs can originate from several tissues such as umbilical cord, bone marrow, adipose, peripheral blood, etc. Genetic manipulation increases regenerative capacities of MSCs in liver diseases. Injection of engineered MSCs can attenuate activation of HSCs, collagen deposition, inflammation, apoptosis and fibrotic processes. MSCs, mesenchymal stem cells; HSCs, hepatic stellate cells

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512